The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
me change notification emails
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
Description of Modification
The Invitation to Submit an Application deadline and the Application Submission deadline have been extended. See the revised Program Announcement, page 1, for dates.
Modification to Previous
Funding Opportunity Number:
Aug 10, 2012
Oct 04, 2012
Original Closing Date for Applications:
Nov 26, 2012
Current Closing Date for Applications:
Dec 03, 2012
Dec 26, 2012
Funding Instrument Type:
Category of Funding Activity:
Science and Technology and other Research and Development
Expected Number of Awards:
Estimated Total Program Funding:
Military Medical Research and Development
Cost Sharing or Matching Requirement:
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Dept. of the Army -- USAMRAA
This funding mechanism encourages research efforts focused on knowledge gathering and geared toward solving specific questions. The TBIRA mechanism DOES NOT ALLOW Clinical Trials. The intent of the TBIRA mechanism is to: promote new/innovative ideas that are still in the early stages of development and have the potential to yield highly impactful data and new avenues of investigation to further the research field of interest; advance knowledge regarding the theoretical construct surrounding the TBI Research Area of interest to increase scientific understanding of certain phenomena or behaviors; propose new paradigms or challenging existing paradigms; and address the technical feasibility of promising new products, pharmacologic agents, behavioral and rehabilitation interventions, diagnostic and therapeutic techniques, clinical guidance, and/or emerging approaches and technologies.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.